127 related articles for article (PubMed ID: 37076469)
1. Association of MicroRNA-652 Expression with Radiation Response of Colorectal Cancer: A Study from Rectal Cancer Patients in a Swedish Trial of Preoperative Radiotherapy.
Pathak S; Meng WJ; Sriramulu S; Jothimani G; Jangamreddy JR; Banerjee A; Ganesan AT; Adell G; Zhang X; Sun-Zhang A; Zhang H; Sun XF
Curr Gene Ther; 2023; 23(5):356-367. PubMed ID: 37076469
[TBL] [Abstract][Full Text] [Related]
2. Expressions of miR-302a, miR-105, and miR-888 Play Critical Roles in Pathogenesis, Radiotherapy, and Prognosis on Rectal Cancer Patients: A Study From Rectal Cancer Patients in a Swedish Rectal Cancer Trial of Preoperative Radiotherapy to Big Database Analyses.
Meng WJ; Pathak S; Zhang X; Adell G; Jarlsfelt I; Holmlund B; Wang ZQ; Zhang AS; Zhang H; Zhou ZG; Sun XF
Front Oncol; 2020; 10():567042. PubMed ID: 33123477
[TBL] [Abstract][Full Text] [Related]
3. WRAP53 is an independent prognostic factor in rectal cancer- a study of Swedish clinical trial of preoperative radiotherapy in rectal cancer patients.
Zhang H; Wang DW; Adell G; Sun XF
BMC Cancer; 2012 Jul; 12():294. PubMed ID: 22805008
[TBL] [Abstract][Full Text] [Related]
4. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinoma.
Yu WD; Peng YF; Pan HD; Wang L; Li K; Gu J
World J Gastroenterol; 2014 Nov; 20(43):16258-67. PubMed ID: 25473181
[TBL] [Abstract][Full Text] [Related]
6. PINCH is an independent prognostic factor in rectal cancer patients without preoperative radiotherapy--a study in a Swedish rectal cancer trial of preoperative radiotherapy.
Holmqvist A; Gao J; Holmlund B; Adell G; Carstensen J; Langford D; Sun XF
BMC Cancer; 2012 Feb; 12():65. PubMed ID: 22325464
[TBL] [Abstract][Full Text] [Related]
7. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
[TBL] [Abstract][Full Text] [Related]
8. AEG-1 expression is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy: a study in a Swedish clinical trial.
Gnosa S; Zhang H; Brodin VP; Carstensen J; Adell G; Sun XF
Br J Cancer; 2014 Jul; 111(1):166-73. PubMed ID: 24874474
[TBL] [Abstract][Full Text] [Related]
9. The early response of p53-dependent proteins during radiotherapy in human rectal carcinoma and in adjacent normal tissue.
Stift A; Prager G; Selzer E; Widder J; Kandioler D; Friedl J; Teleky B; Herbst F; Wrba F; Bergmann M
Int J Oncol; 2003 Nov; 23(5):1269-75. PubMed ID: 14532965
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.
Azizian A; Epping I; Kramer F; Jo P; Bernhardt M; Kitz J; Salinas G; Wolff HA; Grade M; Beißbarth T; Ghadimi BM; Gaedcke J
Int J Mol Sci; 2016 Apr; 17(4):568. PubMed ID: 27092493
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4.
Ha Thi HT; Kim HY; Kim YM; Hong S
Neoplasia; 2019 Sep; 21(9):882-892. PubMed ID: 31387015
[TBL] [Abstract][Full Text] [Related]
12. P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer.
Chen MB; Wu XY; Yu R; Li C; Wang LQ; Shen W; Lu PH
PLoS One; 2012; 7(9):e45388. PubMed ID: 23049793
[TBL] [Abstract][Full Text] [Related]
13. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
14. A systematic approach introduced novel targets in rectal cancer by considering miRNA/mRNA interactions in response to radiotherapy.
Khalighfard S; Kalhori MR; Amiriani T; Poorkhani A; Khori V; Esmati E; Lashkari M; Najafi A; Alizadeh AM
Cancer Biomark; 2022; 33(1):97-110. PubMed ID: 34366323
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-199b Deregulation Shows Oncogenic Properties and Promising Clinical Value as Circulating Marker in Locally Advanced Rectal Cancer Patients.
Santos A; Cristóbal I; Rubio J; Caramés C; Luque M; Sanz-Alvarez M; Morales-Gallego M; Madoz-Gúrpide J; Rojo F; García-Foncillas J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216319
[TBL] [Abstract][Full Text] [Related]
16. Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients.
Stratmann J; Wang CJ; Gnosa S; Wallin A; Hinselwood D; Sun XF; Zhang H
BMC Cancer; 2011 Aug; 11():345. PubMed ID: 21827717
[TBL] [Abstract][Full Text] [Related]
17. Role of peroxiredoxin I in rectal cancer and related to p53 status.
Chen MF; Lee KD; Yeh CH; Chen WC; Huang WS; Chin CC; Lin PY; Wang JY
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):868-78. PubMed ID: 20732753
[TBL] [Abstract][Full Text] [Related]
18. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
Yao YF; Du CZ; Chen N; Chen P; Gu J
Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
[TBL] [Abstract][Full Text] [Related]
19. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy.
Knutsen A; Adell G; Sun XF
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):149-55. PubMed ID: 15337550
[TBL] [Abstract][Full Text] [Related]
20. Special AT-rich sequence binding protein 1 expression correlates with response to preoperative radiotherapy and clinical outcome in rectal cancer.
Meng WJ; Pathak S; Ding ZY; Zhang H; Adell G; Holmlund B; Li Y; Zhou ZG; Sun XF
Cancer Biol Ther; 2015; 16(12):1738-45. PubMed ID: 26528635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
